|
1
|
Patel T: Cholangiocarcinoma -
controversies and challenges. Nat Rev Gastroenterol Hepatol.
8:189–200. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Anderson CD, Pinson CW, Berlin J and Chari
RS: Diagnosis and treatment of cholangiocarcinoma. Oncologist.
9:43–57. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gupta GP and Massague J: Cancer
metastasis: Building a framework. Cell. 127:679–695. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Guarino M, Rubino B and Ballabio G: The
role of epithelial-mesenchymal transition in cancer pathology.
Pathology. 39:305–318. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Vaquero J, Guedj N, Clapéron A, Nguyen
Ho-Bouldoires TH, Paradis V and Fouassier L: Epithelial-mesenchymal
transition in cholangiocarcinoma: From clinical evidence to
regulatory networks. J Hepatol. 66:424–441. 2017. View Article : Google Scholar
|
|
7
|
Heerboth S, Housman G, Leary M, Longacre
M, Byler S, Lapinska K, Willbanks A and Sarkar S: EMT and tumor
metastasis. Clin Transl Med. 4:62015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kelesidis T, Kelesidis I, Chou S and
Mantzoros CS: Narrative review: the role of leptin in human
physiology: emerging clinical applications. Ann Intern Med.
152:93–100. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mohammadzadeh G, Ghaffari MA, Bafandeh A
and Hosseini SM: Association of serum soluble leptin receptor and
leptin levels with breast cancer. J Res Med Sci. 19:433–438.
2014.PubMed/NCBI
|
|
10
|
Karapanagiotou EM, Tsochatzis EA, Dilana
KD, Tourkantonis I, Gratsias I and Syrigos KN: The significance of
leptin, adiponectin, and resistin serum levels in non-small cell
lung cancer (NSCLC). Lung Cancer. 61:391–397. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Brown DR, Berkowitz DE and Breslow MJ:
Weight loss is not associated with hyperleptinemia in humans with
pancreatic cancer. J Clin Endocrinol Metab. 86:162–166. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wallace AM, Sattar N and McMillan DC:
Effect of weight loss and the inflammatory response on leptin
concentrations in gastrointestinal cancer patients. Clin Cancer
Res. 4:2977–2979. 1998.PubMed/NCBI
|
|
13
|
Dutta D, Ghosh S, Pandit K, Mukhopadhyay P
and Chowdhury S: Leptin and cancer: Pathogenesis and modulation.
Indian J Endocrinol Metab. 16(Suppl 3): S596–S600. 2012. View Article : Google Scholar
|
|
14
|
Morris DL and Rui L: Recent advances in
understanding leptin signaling and leptin resistance. Am J Physiol
Endocrinol Metab. 297:E1247–E1259. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wei L, Li K, Pang X, Guo B, Su M, Huang Y,
Wang N, Ji F, Zhong C, Yang J, et al: Leptin promotes
epithelial-mesenchymal transition of breast cancer via the
upregulation of pyruvate kinase M2. J Exp Clin Cancer Res.
35:1662016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Christofk HR, Vander Heiden MG, Harris MH,
Ramanathan A, Gerszten RE, Wei R, Fleming MD, Schreiber SL and
Cantley LC: The M2 splice isoform of pyruvate kinase is important
for cancer metabolism and tumour growth. Nature. 452:230–233. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hamabe A, Konno M, Tanuma N, Shima H,
Tsunekuni K, Kawamoto K, Nishida N, Koseki J, Mimori K, Gotoh N, et
al: Role of pyruvate kinase M2 in transcriptional regulation
leading to epithelial-mesenchymal transition. Proc Natl Acad Sci
USA. 111:15526–15531. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yang WH, Chen JC, Hsu KH, Lin CY, Wang SW,
Wang SJ, Chang YS and Tang CH: Leptin increases VEGF expression and
enhances angiogenesis in human chondrosarcoma cells. Biochim
Biophys Acta. 1840:3483–3493. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Fava G, Alpini G, Rychlicki C, Saccomanno
S, DeMorrow S, Trozzi L, Candelaresi C, Venter J, Di Sario A,
Marzioni M, et al: Leptin enhances cholangiocarcinoma cell growth.
Cancer Res. 68:6752–6761. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
21
|
Wong N and Wang X: miRDB: An online
resource for microRNA target prediction and functional annotations.
Nucleic Acids Res. 43(D1): D146–D152. 2015. View Article : Google Scholar :
|
|
22
|
Li JH, Liu S, Zhou H, Qu LH and Yang JH:
starBase v2.0: Decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA
interaction networks from large-scale CLIP-Seq data. Nucleic Acids
Res. 42(D1): D92–D97. 2014. View Article : Google Scholar
|
|
23
|
Candela r ia PV, Rampoldi A, Ha rbuza r iu
A and Gonzalez-Perez RR: Leptin signaling and cancer
chemoresistance: Perspectives. World J Clin Oncol. 8:106–119. 2017.
View Article : Google Scholar
|
|
24
|
Park J and Scherer PE: Leptin and cancer:
From cancer stem cells to metastasis. Endocr Relat Cancer.
18:C25–C29. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gao C, Patel CJ, Michailidou K, Peters U,
Gong J, Schildkraut J, Schumacher FR, Zheng W, Boffetta P, Stucker
I, et al the Colorectal Transdisciplinary Study (CORECT);
Discovery, Biology and Risk of Inherited Variants in Breast Cancer
(DRIVE); Elucidating Loci Involved in Prostate Cancer
Susceptibility (ELLIPSE); Follow-up of Ovarian Cancer Genetic
Association and Interaction Studies (FOCI); and Transdisciplinary
Research in Cancer of the Lung (TRICL): Mendelian randomization
study of adiposity-related traits and risk of breast, ovarian,
prostate, lung and colorectal cancer. Int J Epidemiol. 45:896–908.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kyrgiou M, Kalliala I, Markozannes, Gunter
MJ, Paraskevaidis E, Gabra H, Martin-Hirsch P and Tsilidis KK:
Adiposity and cancer at major anatomical sites: Umbrella review of
the literature. BMJ. 356:j4772017. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ayoub N, Alkhatatbeh M, Jibreel M and
Ababneh M: Analysis of circulating adipokines in patients newly
diagnosed with solid cancer: Associations with measures of
adiposity and tumor characteristics. Oncol Lett. 13:1974–1982.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Stattin P, Lukanova A, Biessy C, Söderberg
S, Palmqvist R, Kaaks R, Olsson T and Jellum E: Obesity and colon
cancer: Does leptin provide a link? Int J Cancer. 109:149–152.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang D, Gao L, Gong K, Chai Q and Wang G:
Increased serum leptin level in overweight patients with colon
carcinoma: A cross-sectional and prospective study. Mol Clin Oncol.
6:75–78. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Bolukbas FF, Kilic H, Bolukbas C, Gumus M,
Horoz M, Turhal NS and Kavakli B: Serum leptin concentration and
advanced gastrointestinal cancers: A case controlled study. BMC
Cancer. 4:292004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li JS, Han TJ, Jing N, Li L, Zhang XH, Ma
FZ and Liu JY: Obesity and the risk of cholangiocarcinoma: A
meta-analysis. Tumour Biol. 35:6831–6838. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Nitta T, Mitsuhashi T, Hatanaka Y,
Miyamoto M, Oba K, Tsuchikawa T, Suzuki Y, Hatanaka KC, Hirano S
and Matsuno Y: Prognostic significance of epithelial-mesenchymal
transition-related markers in extrahepatic cholangiocarcinoma:
Comprehensive immunohistochemical study using a tissue microarray.
Br J Cancer. 111:1363–1372. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Clapéron A, Mergey M, Nguyen Ho-Bouldoires
TH, Vignjevic D, Wendum D, Chrétien Y, Merabtene F, Frazao A,
Paradis V, Housset C, et al: EGF/EGFR axis contributes to the
progression of cholangiocarcinoma through the induction of an
epithelial-mesenchymal transition. J Hepatol. 61:325–332. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yan D, Avtanski D, Saxena NK and Sharma D:
Leptin-induced epithelial-mesenchymal transition in breast cancer
cells requires β-catenin activation via Akt/GSK3- and MTA1/Wnt1
protein-dependent pathways. J Biol Chem. 287:8598–8612. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Feng H, Liu Q, Zhang N, Zheng L, Sang M,
Feng J, Zhang J, Wu X and Shan B: Leptin promotes metastasis by
inducing an epithelial-mesenchymal transition in A549 lung cancer
cells. Oncol Res. 21:165–171. 2013. View Article : Google Scholar
|
|
36
|
Wei X, Liu Y, Gong C, Ji T, Zhou X, Zhang
T, Wan D, Xu S, Jin P, Yang X, et al: Targeting leptin as a
therapeutic strategy against ovarian cancer peritoneal metastasis.
Anticancer Agents Med Chem. 17:1093–1101. 2017. View Article : Google Scholar
|
|
37
|
Karakatsanis A, Papaconstantinou I,
Gazouli M, Lyberopoulou A, Polymeneas G and Voros D: Expression of
microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c,
miR-221, miR-222, and miR-223 in patients with hepatocellular
carcinoma or intrahepatic cholangiocarcinoma and its prognostic
significance. Mol Carcinog. 52:297–303. 2013. View Article : Google Scholar
|
|
38
|
Wu C, Zhang J, Cao X, Yang Q and Xia D:
Effect of mir-122 on human cholangiocarcinoma proliferation,
invasion, and apoptosis through P53 expression. Med Sci Monit.
22:2685–2690. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Leyva-Illades D, McMillin M, Quinn M and
Demorrow S: Cholangiocarcinoma pathogenesis: Role of the tumor
microenvironment. Transl Gastrointest Cancer. 1:71–80.
2012.PubMed/NCBI
|
|
40
|
Tahergorabi Z and Khazaei M: Leptin and
its cardiovascular effects: Focus on angiogenesis. Adv Biomed Res.
4:792015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Wang Y, Xing QF, Liu XQ, Guo ZJ, Li CY and
Sun G: miR-122 targets VEGFC in bladder cancer to inhibit tumor
growth and angiogenesis. Am J Transl Res. 8:3056–3066.
2016.PubMed/NCBI
|
|
42
|
Azoitei N, Becher A, Steinestel K, Rouhi
A, Diepold K, Genze F, Simmet T and Seufferlein T: PKM2 promotes
tumor angiogenesis by regulating HIF-1α through NF-κB activation.
Mol Cancer. 15:32016. View Article : Google Scholar
|
|
43
|
Li L, Zhang Y, Qiao J, Yang JJ and Liu ZR:
Pyruvate kinase M2 in blood circulation facilitates tumor growth by
promoting angiogenesis. J Biol Chem. 289:25812–25821. 2014.
View Article : Google Scholar : PubMed/NCBI
|
